1. A prospective, multicenter study of bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory iMCD. Issue 3 (23rd February 2022) Authors: Zhang, Lu; Zhang, Miao-yan; Cao, Xin-xin; Zhou, Dao-bin; Fajgenbaum, David C.; Dong, Yu-jun; Li, Jian Journal: Leukemia & lymphoma Issue: Volume 63:Issue 3(2022) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A retrospective study of ultrahigh-risk (Mayo 2004 stage IIIb) AL amyloidosis and identification of predictors related to extremely early death. Issue 7 (7th June 2022) Authors: Gao, Ya-juan; Shen, Kai-ni; Miao, Hui-lei; Tian, Zhuang; Feng, Jun; Zhang, Lu; Cao, Xin-xin; Zhou, Dao-bin; Li, Jian Journal: Leukemia & lymphoma Issue: Volume 63:Issue 7(2022) Page Start: 1758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bortezomib-based chemotherapy reduces early mortality and improves outcomes in patients with ultra-high-risk light-chain amyloidosis: a retrospective case control study. (3rd April 2019) Authors: Shen, Kai-Ni; Zhang, Cong-Li; Tian, Zhuang; Feng, Jun; Wang, Yi-Ning; Sun, Jian; Zhang, Lu; Cao, Xin-Xin; Zhou, Dao-bin; Li, Jian Journal: Amyloid Issue: Volume 26:Number 2(2019) Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) associated with or without lymphoma: Comparison of clinical features and risk factors suggestive of underlying lymphomas. (August 2019) Authors: Zhang, Lu; Liu, Xiao-hang; Jin, Fan; Liu, Mei-xi; Zhang, Meng; Zhang, Yan; Zhou, Dao-bin; Zhang, Wei Journal: Journal of clinical neuroscience Issue: Volume 66(2019) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Characteristics, Outcomes, and Risk Factors for Patients with Diffuse Large B-Cell Lymphoma and Development of Nomogram to Identify High-Risk Patients. (17th November 2022) Authors: Zhao, Jinrong; Zhang, Yan; Wang, Wei; Zhang, Wei; Zhou, Dao-bin Other Names: Qian Liren Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical presentation and prognosis of immunoglobulin light-chain amyloidosis with high percentage of bone marrow plasma cells. (June 2019) Authors: Zhang, Cong-li; Qiu, Yu; Shen, Kai-ni; Miao, Hui-lei; Feng, Jun; Cao, Xin-xin; Zhang, Lu; Jiang, Xian-yong; Zhou, Dao-bin; Li, Jian Journal: Leukemia research Issue: Volume 81(2019) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical presentation and prognostic analysis of Chinese patients with systemic light chain amyloidosis with liver involvement. (November 2019) Authors: Zhang, Le-le; Shen, Kai-ni; Zhang, Cong-li; Qiu, Yu; Miao, Hui-lei; Feng, Jun; Cao, Xin-xin; Zhang, Lu; Zhou, Dao-bin; Li, Jian Journal: Leukemia research Issue: Volume 86(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Corrigendum to "Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis" Leuk. Res. 120C (2022) 106917. (January 2023) Authors: Gao, Ya-juan; Shen, Kai-ni; Chang, Long; Feng, Jun; Mao, Yue-ying; Zhang, Lu; Cao, Xin-xin; Zhou, Dao-bin; Li, Jian Journal: Leukemia research Issue: Volume 124(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial. Issue 1 (4th January 2022) Authors: Shen, Kai-ni; Fu, Wei-jun; Wu, Yu; Dong, Yu-jun; Huang, Zhong-xia; Wei, Yong-qiang; Li, Chun-rui; Sun, Chun-yan; Chen, Ye; Miao, Hui-lei; Zhang, Yue-lun; Cao, Xin-xin; Zhou, Dao-bin; Li, Jian Journal: Circulation Issue: Volume 145:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study. (October 2022) Authors: Cao, Xin-xin; Jin, Jie; Fu, Cheng-cheng; Yi, Shu-hua; Zhao, Wei-li; Sun, Zi-min; Yang, Wei; Li, Deng-ju; Cui, Guo-hui; Hu, Jian-da; Liu, Ting; Song, Yong-ping; Xu, Bing; Zhu, Zun-min; Xu, Wei; Zhang, Ming-zhi; Tian, Ya-min; Zhang, Bin; Zhao, Ren-bin; Zhou, Dao-bin Journal: EClinicalMedicine Issue: Volume 52(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗